Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Pharmacogenet Genomics. 2012 Jan;22(1):32–42. doi: 10.1097/FPC.0b013e32834e1641

Figure 1. Derivation of the study cohort.

Figure 1

After applying inclusion criteria to the Synthetic Derivative, 527 subject samples were eligible for genotyping. Of these, 13 were removed for sex misclassification, 28 after DMET Plus quality control (QC), and 31 after iPlex Gold QC.